top of page
Search
May 29, 20249 min read
Our Parent Company, RespireRx Pharmaceuticals Inc., Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Improve Bladder Function in Patients with Spinal Cord Injury
RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and...
Feb 13, 202410 min read
Our Parent Company, RespireRx Pharmaceuticals Inc., Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine
Glen Rock, N.J., February 13, 2024 /Globe Newswire - RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the...
Jan 22, 20249 min read
Our Parent Company, RespireRx Pharmaceuticals Inc., Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
Glen Rock, N.J., January 22, 2024 /Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”),...
bottom of page